The Dose-Dependent Effects of Spironolactone on TGF-<i>β</i>1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats

Cardiology Research and Practice

fig1

Figure 1

Figure 1: The Dose-Dependent Effects of Spironolactone on TGF-<i>β</i>1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats 

Figure 1 | The Dose-Dependent Effects of Spironolactone on TGF-β1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats 